Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Jiaorong Qu, Le Wang, Xiaojiaoyang Li

Clin Mol Hepatol. 2024;30(4):1002-1004. Published online May 17, 2024

DOI: https://doi.org/10.3350/cmh.2024.0357

View: 1546 Download: 51

Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li

Clin Mol Hepatol. 2024;30(4):585-619. Published online July 1, 2024

DOI: https://doi.org/10.3350/cmh.2024.0222

View: 3404 Download: 313 Web of Science: 3 Crossref: 4

Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li

Clin Mol Hepatol. 2024;30(3):303-325. Published online February 28, 2024

DOI: https://doi.org/10.3350/cmh.2024.0022

View: 5882 Download: 337 Web of Science: 8 Crossref: 10

1 |

Viewed By 7187	MAFLD: How is it different from NAFLD?
Viewed By 6636	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5470	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5259	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4735	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 269	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 181	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 88	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search